Insider Trading activities at Immunosyn Corp (IMYN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunosyn Corp (IMYN) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Immunosyn Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1375623.

Total stock buying since 2007: $41,010.
Total stock sales since 2007: $15,552,908.
Total stock option exercises since 2007: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Immunosyn Corp (IMYN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2009 573,137 $41,010 0 $0 0 $0
2008 0 $0 800,000 $4,000,000 0 $0
2007 250,000 $0 2,222,090 $11,552,908 0 $0

Table 2. Monthly summary of insider trading at Immunosyn Corp (IMYN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-08 177,000 $9,620 0 $0 0 $0
2009-07 346,137 $27,890 0 $0 0 $0
2009-06 50,000 $3,500 0 $0 0 $0
2008-03 0 $0 800,000 $4,000,000 0 $0
2007-11 0 $0 26,665 $199,985 0 $0
2007-10 0 $0 1,300,771 $7,015,380 0 $0
2007-08 250,000 $0 731,540 $3,521,973 0 $0
2007-06 0 $0 163,114 $815,570 0 $0

Table 3. Detailed insider trading at Immunosyn Corp (IMYN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-08-31 Miceli James T (10% Owner) Buy 100,000 .05 5,000
2009-08-26 Miceli James T (10% Owner) Buy 77,000 .06 4,620
2009-07-28 Miceli James T (10% Owner) Buy 50,000 .07 3,500
2009-07-27 Miceli James T (10% Owner) Buy 50,000 .07 3,500
2009-07-22 Miceli James T (10% Owner) Buy 52,500 .07 3,937
2009-07-20 Miceli James T (10% Owner) Buy 12,780 .08 1,022
2009-07-15 Miceli James T (10% Owner) Buy 61,500 .09 5,658
2009-07-14 Miceli James T (10% Owner) Buy 50,000 .09 4,600
2009-07-13 Miceli James T (10% Owner) Buy 10,000 .08 800
2009-07-10 Miceli James T (10% Owner) Buy 10,000 .09 900
2009-07-08 Miceli James T (10% Owner) Buy 36,500 .09 3,102
2009-07-07 Miceli James T (10% Owner) Buy 10,000 .07 700
2009-07-06 Miceli James T (10% Owner) Buy 2,857 .06 171
2009-06-30 Miceli James T (10% Owner) Buy 50,000 .07 3,500
2008-03-13 Mcclain Douglas A Jr (Chief Financial Officer) Sale 400,000 5.00 2,000,000
2008-03-13 Argyll Biotechnologies Llc (10% Owner) Sale 400,000 5.00 2,000,000
2007-11-01 Miceli James T (10% Owner) Sale 5,333 7.50 39,997
2007-11-01 Mcclain Douglas A Jr (CBO, Secretary) Sale 10,666 7.50 79,994
2007-11-01 Argyll Biotechnologies Llc (10% Owner) Sale 5,333 7.50 39,997
2007-10-24 Miceli James T (10% Owner) Sale 8,000 5.00 40,000
2007-10-24 Mcclain Douglas A Jr (CBO, Secretary) Sale 24,000 5.00 120,000
2007-10-24 Argyll Biotechnologies Llc (10% Owner) Sale 16,000 5.00 80,000
2007-10-18 Miceli James T (10% Owner) Sale 193,783 6.88 1,332,258
2007-10-18 Mcclain Douglas A Jr (CBO, Secretary) Sale 193,783 6.88 1,332,258
2007-10-18 Argyll Biotechnologies Llc (10% Owner) Sale 115,067 6.25 719,168
2007-10-03 Miceli James T (10% Owner) Sale 367,069 4.51 1,655,848
2007-10-03 Mcclain Douglas A Jr (CBO, Secretary) Sale 367,069 4.51 1,655,848
2007-08-24 Miceli James T (10% Owner) Buy 125,000 .00 0
2007-08-24 Mcclain Douglas A Jr (CBO, Secretary) Buy 125,000 .00 0
2007-08-23 Miceli James T (10% Owner) Sale 192,470 4.85 933,479
2007-08-23 Padmore Holdings Ltd (10% Owner) Sale 346,600 4.78 1,655,015
2007-08-23 Mcclain Douglas A Jr (CBO, Secretary) Sale 192,470 4.85 933,479
2007-06-12 Miceli James T (10% Owner) Sale 38,632 5.00 193,160
2007-06-12 Padmore Holdings Ltd (10% Owner) Sale 85,850 5.00 429,250
2007-06-12 Mcclain Douglas A Jr (CBO, Secretary) Sale 38,632 5.00 193,160

Insider trading activities including stock purchases, stock sales, and option exercises of IMYN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immunosyn Corp (symbol IMYN, CIK number 1375623) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.